A Bayesian Bernoulli-Exponential joint model for binary longitudinal outcomes and informative time with applications to bladder cancer recurrence data.

Publication Year: 2024

DOI:
10.1186/s12874-024-02160-2

PMCID:
PMC10905822

PMID:
38429679

Journal Information

Full Title: BMC Med Res Methodol

Abbreviation: BMC Med Res Methodol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateEthical approval was not required for this study since the data used for this study are secondary data and openly/publicly available in R software. Consent for publicationNot applicable. Competing interestsThe author declares no competing interests. Also, the author currently works for Pfizer Inc. Results, views or research findings expressed in this manuscript do not necessarily reflect those of Pfizer, Inc. Competing interests The author declares no competing interests. Also, the author currently works for Pfizer Inc. Results, views or research findings expressed in this manuscript do not necessarily reflect those of Pfizer, Inc."

Evidence found in paper:

"Funding This project was self-funded."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025